ENTECAVIR ANHYDROUS

SynDRA canonical compound SYN0001538 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Mechanism of action	DNA replication inhibitor \| nucleoside reverse transcriptase inhibitor
Indication	hepatitis B
Disease area	infectious disease

All known targets

entecavir
entecavir monohydrate
anhydrous entecavir
BMS-200475-01
baraclude
entecavir hydrate
Anhydrous entecavir
Entecavir
Baraclude
ETV
Entecavir hydrate
Entecavir monohydrate
BMS-200475
Baraclude (TN)
Entecavir (INN)
Entecavir (USAN)
Entecavir hydrate (JAN)
SQ-34676
2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one-water (1/1)
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one
6-H-Purin-6-one-,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]
9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)guanine monohydrate
SQ34676
ENTECAVIR
Entecavir Hydrate
NNU2O4609D
entecavir monohydrate (usp-rs)
entecavir (usp monograph)
BMS 200475-01
entecavir monohydrate (ep monograph)
entecavir (anhydrous)
CHEBI:473990
DTXCID2026446
Entecavirum
RefChem:5792
J05AF10